Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Tosoh Bioscience, a leading name in the research and development services sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2002, the company has established itself as a key player in the biopharmaceutical and life sciences industries, focusing on innovative solutions for analytical and preparative chromatography.
With a diverse portfolio that includes high-performance liquid chromatography (HPLC) columns, mass spectrometry products, and bioseparation technologies, Tosoh Bioscience is renowned for its commitment to quality and precision. The company’s unique offerings cater to a wide range of applications, from drug development to environmental analysis, positioning it as a trusted partner in scientific research. Notable achievements include significant advancements in bioprocessing and a strong reputation for customer support, solidifying its market position as a preferred choice for researchers and laboratories worldwide.
+5 vs industry average
Tosoh Bioscience’s score of 35 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has typical carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
Tosoh Bioscience is committed to reducing its environmental impact. For fiscal year 2024, the company reported total global emissions of approximately 13.4 billion kg CO2e. This comprised about 7.3 billion kg CO2e in Scope 1 emissions and approximately 468 million kg CO2e in Scope 2 emissions, alongside 5.8 billion kg CO2e in Scope 3 emissions.
Looking at previous years, global emissions for fiscal year 2023 were approximately 13.9 billion kg CO2e, with Scope 1 accounting for about 7.6 billion kg CO2e, Scope 2 for around 467 million kg CO2e, and Scope 3 for approximately 5.9 billion kg CO2e.
Tosoh Bioscience has set a clear climate target: to reduce Scope 1 and 2 greenhouse gas emissions by 30% in fiscal year 2031, compared to a fiscal year 2019 baseline. This long-term commitment underscores their dedication to climate action within the research and development services sector. The company's emissions data is inherited from its ultimate parent company, Tosoh Corporation, as indicated by the cascaded data.
Access structured emission data, company specific factors and auditable source documents
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more